Marc Debled
AuthID: R-00G-SRM
1
TITLE: Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
AUTHORS: Melanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Ozguroglu; Sergio J Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J Gradishar; Christina Arce; Antonia Ridolfi; Chinjune J Lin; Fatima Cardoso;
PUBLISHED: 2018, SOURCE: JAMA ONCOLOGY, VOLUME: 4, ISSUE: 7
AUTHORS: Melanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Ozguroglu; Sergio J Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J Gradishar; Christina Arce; Antonia Ridolfi; Chinjune J Lin; Fatima Cardoso;
PUBLISHED: 2018, SOURCE: JAMA ONCOLOGY, VOLUME: 4, ISSUE: 7
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTORPOSITIVE (ER plus ), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) METASTATIC OR LOCALLY ADVANCED UNRESECTABLE BREAST CANCER (BC) Full Text
AUTHORS: Thomas Bachelot; Cristian Villanueva; Melanie Royce; Marc Debled; Felipe Melo Cruz; Roberto Hegg; Thomas Brechenmacher; Corinne Manlius; Francois Ringeisen; Fatima Cardoso;
PUBLISHED: 2015, SOURCE: BREAST, VOLUME: 24
AUTHORS: Thomas Bachelot; Cristian Villanueva; Melanie Royce; Marc Debled; Felipe Melo Cruz; Roberto Hegg; Thomas Brechenmacher; Corinne Manlius; Francois Ringeisen; Fatima Cardoso;
PUBLISHED: 2015, SOURCE: BREAST, VOLUME: 24
INDEXED IN: WOS
WOS